VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

BSC® Solutions

Stuck or in trouble

BSC® Solutions

Stuck or in trouble

If you're on this page, something has gone wrong. Let's fix it.

Maybe FDA came back with questions you weren't expecting. Maybe your submission was rejected and you're trying to understand why. Maybe you inherited a study from a statistician who left things in worse shape than anyone realized. Maybe your deadline is in six weeks and your team is underwater.

Whatever the situation, you need experienced help — fast.

We've seen it before. We know how to move.

BSC has spent nearly four decades working on programs that didn't go according to plan. We've responded to FDA deficiency letters, rescued analyses from statistical errors, rebuilt submission packages under impossible timelines, and untangled the kind of data and documentation problems that make internal teams freeze.

We don't panic. We assess, prioritize, and execute.

When you bring BSC in on a troubled program, the first thing we do is tell you the truth — about what the situation actually is, what's salvageable, what your options are, and what it will take to move forward. No false reassurance. No overpromising. Just clear, experienced judgment from people who have navigated worse.

Common situations we step into

  • FDA deficiency letter or Additional Information request — We assess the questions, evaluate your existing analyses, and develop a response strategy that is scientifically sound and directly responsive to what FDA is asking

  • Failed submission or Complete Response — We conduct a thorough review of what was submitted, identify the statistical vulnerabilities, and develop a remediation plan

  • Previous statistician dropped the ball — We audit existing work, identify gaps and errors, and rebuild what needs to be rebuilt — cleanly, thoroughly, and with full documentation

  • Tight deadline, no margin for error — We staff up, prioritize ruthlessly, and deliver — without cutting corners on quality or regulatory defensibility

What we do in these engagements

Drawing on our Analyze and Advance services, we support:

  • Rapid assessment and situation analysis

  • FDA deficiency response development

  • Statistical audit of prior work

  • Rescue analysis and alternative analytical frameworks

  • Emergency programming and TLF regeneration

  • Submission package remediation

  • Direct regulatory strategy support

This is not the time for the wrong partner

When a program is in trouble, the instinct is to move fast. That's right. But moving fast with the wrong team makes things worse. FDA responses require precision. Rescue analyses require defensibility. Rebuilt submission packages require the kind of rigor that holds up when reviewers look closely.

BSC delivers speed without sacrificing the quality that regulatory submissions demand. We've done it before. We'll do it for you.

If you're in trouble, call us. The sooner we start, the more options you have.

Design

We use innovative approaches such as Bayesian design, adaptive clinical trial design, and Propensity Score Matching to save costs, work around limited access to new data, and reduce bias in non-randomized studies.

Analyze

Advance

Testimonials

See what our sponsors say about BSC

On Experience

Battle ground tested. There is nothing that David and team haven't seen over the years – good bad and ugly.

• VP, Clinical Operations

• CEO, Medical Device Company

• Former FDA Regulator

Questions answered

Any other question?

Let's help you find a path

to get your idea into the market

  • About & Services

    Working With BSC

    Trial Design & Methodology

    Regulatory & FDA

    Analysis & Programming

    Cost & Contracting

    Expertise & Qualifications

    Practical Considerations

    Common Concerns

  • What does BSC specialize in?

    What types of clients do you work with?

    What therapeutic areas do you cover?

    How is BSC different from a CRO?

    What size projects do you handle?

Questions answered

Any other question?

Let's help you find a path

to get your idea into the market

  • About & Services

    Working With BSC

    Trial Design & Methodology

    Regulatory & FDA

    Analysis & Programming

    Cost & Contracting

    Expertise & Qualifications

    Practical Considerations

    Common Concerns

  • What does BSC specialize in?

    What types of clients do you work with?

    What therapeutic areas do you cover?

    How is BSC different from a CRO?

    What size projects do you handle?

Questions answered

Any other question?

Let's help you find a path

to get your idea into the market

  • About & Services

    Working With BSC

    Trial Design & Methodology

    Regulatory & FDA

    Analysis & Programming

    Cost & Contracting

    Expertise & Qualifications

    Practical Considerations

    Common Concerns

  • What does BSC specialize in?

    What types of clients do you work with?

    What therapeutic areas do you cover?

    How is BSC different from a CRO?

    What size projects do you handle?

Questions answered

Any other question?

Let's help you find a path

to get your idea into the market

  • About & Services

    Working With BSC

    Trial Design & Methodology

    Regulatory & FDA

    Analysis & Programming

    Cost & Contracting

    Expertise & Qualifications

    Practical Considerations

    Common Concerns

  • What does BSC specialize in?

    What types of clients do you work with?

    What therapeutic areas do you cover?

    How is BSC different from a CRO?

    What size projects do you handle?

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Security

Robust data security and confidentiality

across sensitive, FDA-regulated clinical and regulatory data.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

GDPR

SOC2 - in progress

For more information visit our trust center

Security

Robust data security and confidentiality

across sensitive, FDA-regulated clinical and regulatory data.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

GDPR

SOC2 - in progress

For more information visit our trust center

Security

Robust data security and confidentiality

across sensitive, FDA-regulated clinical and regulatory data.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

GDPR

SOC2 - in progress

For more information visit our trust center

Security

Robust data security and confidentiality

across sensitive, FDA-regulated clinical and regulatory data.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

Disciplined security practices aligned with industry standards to protect confidential patient, sponsor, and regulatory information.

GDPR

SOC2 - in progress

For more information visit our trust center

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.